02/07/2020
3:20 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2020
3:52 PM | Adaptimmune Therapeutics (Issuer)
Florence Anthony A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2020
3:52 PM | Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2020
3:51 PM | Adaptimmune Therapeutics (Issuer)
BASKETT FOREST (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2020
4:31 PM | Adaptimmune Therapeutics (Filer)
| Form 424B5
| |
01/22/2020
4:30 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2020
4:21 PM | Adaptimmune Therapeutics (Filer)
| Form 424B5
| |
01/17/2020
8:48 PM | Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2020
8:35 PM | Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2020
8:33 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2020
8:31 PM | Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2020
8:30 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
7:03 PM | Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
7:03 PM | Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
7:02 PM | Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
7:02 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
7:01 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
7:01 PM | Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2020
5:17 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
7:02 PM | Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/13/2020
7:42 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
6:09 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2020
7:01 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2020
7:01 PM | Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2020
7:00 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2019
10:55 AM | Adaptimmune Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2019
6:35 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2019
8:30 PM | Adaptimmune Therapeutics (Issuer)
Garone Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2019
7:14 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2019
7:59 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2019
11:15 PM | Adaptimmune Therapeutics (Filer)
| Form EFFECT
| |
09/03/2019
8:00 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2019
12:06 PM | Adaptimmune Therapeutics (Subject)
Citibank,N.A./ADR (Filed by)
| Form F-6EF
| |
08/30/2019
11:30 AM | Adaptimmune Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/30/2019
11:26 AM | Adaptimmune Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/27/2019
7:39 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2019
8:00 PM | Adaptimmune Therapeutics (Issuer)
Amado Rafael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2019
8:03 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2019
8:02 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/01/2019
10:59 AM | Adaptimmune Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2019
6:23 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2019
6:22 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2019
7:07 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2019
7:08 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2019
7:11 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2019
4:41 PM | Adaptimmune Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:40 PM | Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:01 PM | Adaptimmune Therapeutics (Issuer)
Zaks Tal Zvi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:00 PM | Adaptimmune Therapeutics (Issuer)
Furey John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:00 PM | Adaptimmune Therapeutics (Issuer)
Kerr Giles Francis Bertram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:00 PM | Adaptimmune Therapeutics (Issuer)
Sigal Charles Elliott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:00 PM | Adaptimmune Therapeutics (Issuer)
Duncan Barbara Gayle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
4:00 PM | Adaptimmune Therapeutics (Issuer)
Alleva Lawrence M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
7:00 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
7:08 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2019
5:00 PM | Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2019
7:11 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2019
1:57 PM | Adaptimmune Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2019
7:11 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2019
6:38 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2019
6:08 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2019
3:56 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2019
6:10 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2019
7:10 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2019
4:01 PM | Adaptimmune Therapeutics (Filer)
| Form DEF 14A
| |
03/01/2019
4:01 PM | Adaptimmune Therapeutics (Filer)
| Form PRE 14A
| |
02/27/2019
4:22 PM | Adaptimmune Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2019
4:16 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K/A
| |
02/27/2019
6:43 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
4:00 PM | Adaptimmune Therapeutics (Subject)
Cross Nicholas John (Filed by)
| Form SC 13G/A
| |
01/16/2019
8:31 PM | Adaptimmune Therapeutics (Issuer)
Binder-Scholl Gwendolyn Knowlton (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2019
8:31 PM | Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2019
8:31 PM | Adaptimmune Therapeutics (Issuer)
Amado Rafael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2019
8:30 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2019
8:00 AM | Adaptimmune Therapeutics (Subject)
Matrix Capital Management Company, LP (Filed by)
| Form SC 13G/A
| |
01/08/2019
8:02 PM | Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
8:01 PM | Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
8:01 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
8:01 PM | Adaptimmune Therapeutics (Issuer)
Amado Rafael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
8:00 PM | Adaptimmune Therapeutics (Issuer)
Noble James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
6:40 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2018
7:04 PM | Adaptimmune Therapeutics (Issuer)
Alleva Lawrence M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2018
7:39 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2018
9:58 AM | Adaptimmune Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2018
6:36 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2018
7:38 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2018
3:10 PM | Adaptimmune Therapeutics (Subject)
Matrix Capital Management Company, LP (Filed by)
| Form SC 13G/A
| |
10/10/2018
1:37 PM | Adaptimmune Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A
| |
10/02/2018
6:58 PM | Adaptimmune Therapeutics (Issuer)
Binder-Scholl Gwendolyn Knowlton (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2018
2:45 PM | Adaptimmune Therapeutics (Subject)
New Enterprise Associates 14, L.P. (Filed by)
| Form SC 13D
| |
09/10/2018
3:49 PM | Adaptimmune Therapeutics (Issuer)
Viswanathan Ravi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2018
3:49 PM | Adaptimmune Therapeutics (Issuer)
Sonsini Peter W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2018
3:49 PM | Adaptimmune Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2018
3:48 PM | Adaptimmune Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2018
3:48 PM | Adaptimmune Therapeutics (Issuer)
KERINS PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2018
3:47 PM | Adaptimmune Therapeutics (Issuer)
Florence Anthony A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2018
3:47 PM | Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2018
3:46 PM | Adaptimmune Therapeutics (Issuer)
BASKETT FOREST (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2018
3:46 PM | Adaptimmune Therapeutics (Issuer)
BARRIS PETER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2018
3:45 PM | Adaptimmune Therapeutics (Issuer)
BARRETT M JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
